ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
41.02
0.32%
US Tech 100
20,628.60
0.08%
S&P 500
6,047.82
0.01%
US Dollar vs CAD
1.40567
0.08%
Bitcoin
95,689.81
-0.17%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. Europe
  5. EU

  6. Biomerieux (BIM) Share Price

Biomerieux

Biomerieux (BIM)

Bindi Metals Ltd
Banca Intermobiliare SpA
97.00
-0.50
(-0.51%)
Closed December 03 10:30AM
Delayed by 15 minutes

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Key stats and details

Current Price
97.00
Bid
96.80
Ask
97.30
Volume
83,033
96.80 Day's Range 97.85
88.25 52 Week Range 111.50
Market Cap
11.441B
Previous Close
97.50
Open
97.60
Last Trade
562
@
97
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
107,659
Shares Outstanding
117,946,146
Dividend Yield
0.88%
PE Ratio
31.99
Earnings Per Share (EPS)
3.03
Revenue
3.67B
Net Profit
357.6M

About Biomerieux

Sector
Biological Pds,ex Diagnstics
Industry
Biological Pds,ex Diagnstics
Website
www.biomerieux.com
Headquarters
Lyon, Rhone, Fra
Founded
-
Biomerieux is listed in the Biological Pds,ex Diagnstics sector of the Euronext with ticker BIM. The last closing price for Biomerieux was 97.50 €. Over the last year, Biomerieux shares have traded in a share price range of 88.25 € to 111.50 €.

Biomerieux currently has 117,946,146 shares outstanding. The market capitalization of Biomerieux is 11.50 € billion. Biomerieux has a price to earnings ratio (PE ratio) of 31.99.

Ask ADVFN Intelligence (AI)

BIM Latest News

More News

Oxford Nanopore and bioMérieux to Enter Into a Strategic Partnership Agreement to Develop Innovative Infectious Disease Diagnostics

Oxford Nanopore Technologies plc (LSE: ONT) (“Oxford Nanopore”), the company delivering a new generation of nanopore-based molecular sensing technology, and bioMérieux SA, a world leader in the...

April 14 2023
Business Wire

Baxter and bioMérieux Announce CE Mark for NEPHROCLEAR™ CCL14 Test to Predict Persistent Severe Acute Kidney Injury

Reinforces Baxter and bioMérieux’s shared commitment to enhancing acute kidney injury (AKI) management through informed clinical decision-making and patient-centered approaches Aids hospitals in...

October 21 2021
Business Wire

bioMérieux : Avis de mise à disposition des documents préparatoires à l’Assemblée générale mixte du 20 mai 2021

Regulatory News: Une Assemblée générale mixte des actionnaires de bioMérieux (Paris:BIM) (la « Société ») est convoquée le 20 mai 2021, à 14 heures, au 376, Chemin de l’Orme, 69280 Marcy...

April 09 2021
Business Wire

bioMérieux : Informations mensuelles relatives au nombre total de droits de vote et d’actions prévues par l’article L. ...

Regulatory News: bioMérieux (Paris:BIM) : Code : BIM - Code ISIN : FR0013280286 Date d’arrêt des informations Nombre d’actions Nombre total de droits de vote   31/03/2021   118 361 220 Nombre...

April 07 2021
Business Wire

bioMérieux Announces the CE Marking of TB IGRA® Test on VIDAS®

Regulatory News: Today marks World Tuberculosis (TB) Day and bioMérieux (Paris:BIM), a world leader in the field of in vitro diagnostics, announces the CE marking of its innovative and...

March 23 2021
Business Wire

bioMérieux reçoit une autorisation De Novo de la FDA pour le panel Respiratoire BIOFIRE® 2.1 (RP2.1) incluant le SARS-CoV-2

Regulatory News: bioMérieux (Paris:BIM), acteur majeur dans le domaine du diagnostic in vitro, annonce que sa filiale spécialisée dans les tests syndromiques des maladies infectieuses, BioFire...

March 18 2021
Business Wire

bioMérieux : Communiqué de mise à disposition du Document d’enregistrement universel incluant le rapport financier annue...

Regulatory News: Le Document d’enregistrement universel incluant le rapport financier annuel au 31 décembre 2020 de bioMérieux (Paris:BIM) a été déposé auprès de l'Autorité des Marchés...

March 17 2021
Business Wire
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.9-0.91930541368797.9100.196.86662598.72559175DE
4-5.7-5.55014605648102.7104.59611233999.66116453DE
12-12.8-11.6575591985109.8111.196107659104.33010993DE
26-0.45-0.46177526936997.45111.588.2594610100.27330715DE
52-3.7-3.67428003972100.7111.588.259705299.95763972DE
156-21.35-18.0397127165118.35129.677.4810408797.28603327DE
26016.5520.571783716680.45144.875116059102.55226556DE

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
ALCYBCybergun
0.0002 €
(100.00%)
10.06M
ALVETEGEIRO Pharma
0.124 €
(58.97%)
481.8k
ALDVAlliance Developpement Capital Siic
0.074 €
(32.14%)
6k
MLSRPSpeed Rabbit Pizza
8.20 €
(30.16%)
19
MLSEQSequa Petroleum NV
0.011 €
(29.41%)
12k
MLCOTCoretech 5
0.01 €
(-41.18%)
200
ATOAtos SE
0.495 €
(-32.65%)
17.92M
AFMEAffluent Medical
1.20 €
(-21.05%)
21.92k
ALBIOBiosynex
2.095 €
(-18.32%)
26.9k
TRACTTeract SA
1.03 €
(-15.23%)
76.91k
BCPBanco Comercial Portugues SA
0.4457 €
(2.20%)
44.64M
ALNEVNeovacs
0.0003 €
(0.00%)
33.59M
ATOAtos SE
0.495 €
(-32.65%)
17.92M
ALCYBCybergun
0.0002 €
(100.00%)
10.06M
ORAOrange.
9.706 €
(-2.99%)
9.65M

Discussion

View Full Feed
chonrm chonrm 4 minutes ago
Looking more and more like a scam here...
OCLG
surfkast surfkast 4 minutes ago
Lets not forget Emma was on Dancing With the Stars this Fall and she will be doing the 2025 DWTS Tour starting January until April!
Scamdale is so FOS and anyone else pumping this scam! Clown claimed she would be dancing right up the street and doing both shows!
So with the US tour wil
MWWC
getReady getReady 4 minutes ago
We are at day 13 Obviously , something, waiting on something.
ASII
AyaStocks AyaStocks 4 minutes ago
Nice buys hitting $SPRV , +33.33%
SPRV
diamondguru-one diamondguru-one 5 minutes ago
shorts coving....NOBODY is selling at these prices
KULR
AyaStocks AyaStocks 5 minutes ago
Nice buys hitting $SPRV , +33.33%
SPRV
toohot toohot 5 minutes ago
Look, I realize you probably don’t own any shares. But you’re way off base here. More scare tactics for newbies.
The MundiPharma suit is still on the table. No reverse split until profitable. How many times do we have to repeat this?
‘Nuff said!




BIEL
JustJack JustJack 5 minutes ago
Have you seen the YouTube videos by Brad & Bradley?

A good look at the AITX devices from real people in the YouTube world?

Do you think they are independent of AITX? Steve makes it seem that way.

Well Steve made them up.

https://investorshu
AITX
glenn1919 glenn1919 5 minutes ago
MULN.............................................fillthegap............................https://stockcharts.com/h-sc/ui?s=muln&p=D&yr=0&mn=2&dy=12&id=p84071410134
MULN
TONTOYO TONTOYO 5 minutes ago
I'm currently using coinbase, I will need some cash though to be debt free, coinbase or another platform?
XRPUSD
jtomm jtomm 5 minutes ago
TGEN ($1.12) Finally bought a few of this one at $1.03 when it plunged this morning. Over the holiday week, I totally missed that they had announced some big orders:

https://www.otcmarkets.com/stock/tgen/news/Tecogen-Receives-Orders-for-7-DTX-Chillers-for-Las-Vegas-Convention-Center?i
The Night Stalker The Night Stalker 5 minutes ago
NICE
WONDF
Zorax Zorax 5 minutes ago
Because mush is a coward. As with all super rich, only other people take his risks. Not themselves.

https://www.inverse.com/innovation/is-elon-musk-going-to-space-spacex-ceo-has-yet-to-follow-bezos-branson
fink fink 5 minutes ago
I'm set up for the EOD bear attack.
Feed me!

Better me get those shares than the next guy. LOL
AZRH
bbotcs bbotcs 6 minutes ago
r59: SMCI
I have sold puts at least a dozen times this year when I should have bought the stock, or done both!
SMCI
Lone Clone Lone Clone 6 minutes ago
SAGA Metals Reports Channel Sample Assay Results at Double Mer Uranium Project

https://www.globenewswire.com/news-release/2024/12/03/2990726/0/en/SAGA-Metals-Reports-Channel-Sample-Assay-Results-at-Double-Mer-Uranium-Project.html

December 03, 2024 09:00 ET | Source: Sag
bwrbad bwrbad 6 minutes ago
MCD started testing another new drive through ai voice again after sacking IBM, If they using SOUN-EMILIA and adopt them then that should be the news of the year for SOUNDHOUND
MCD SOUN
packerfan9 packerfan9 6 minutes ago
What nonsense. How is this undervalued? Last income statement showed 167,000 in sales. Vs billions of new shares being sold. It's over valued. Ignore the oast here like you are. When they dilute it down to .00001 yet again. You will be stuck. Just ask shareholders who bought down there before last r
CBDL
hopester hopester 6 minutes ago
UBS lowers its px tgt from $15 to $13.75 and maintains Neutral rating.
UBS
TONTOYO TONTOYO 7 minutes ago
When I sell some XRP to take some profits is cheaper to sell into stable coin? USDT or USDC?
XRPUSD
JusticeWillWin JusticeWillWin 7 minutes ago
Market completely ignoring COOP's BALANCED BUSINESS MODEL which is PROFITABLE in low AND high rate environments....

COOP @ $120+ in February 2025 IMO
COOP
CommodityCoverage CommodityCoverage 7 minutes ago
Delivering significant updates on the project's progress, Heliostar Metals (HSTR.v HSTXF) additional high-grade gold results with key highlights including 87.8 meters grading 16.0 g/t gold, including 16.1 meters at 71.8 g/t gold and 125.9 meters grading 4.02 g/t gold at its Ana Paula Project in Guer
HSTXF

Your Recent History

EU
BIM
Biomerieux
COIN
AURORAAETH
Aurora
COIN
GHSTETH
Aavegotchi GHST Token
ASX
BLU
Blue Energy
LSE
WTE
Westmount Energy
BOV
RAIL3
RUMO S.A ON
DOWI
DJUSMU
DJ US Multiutilities
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved